ArticleCureus2025
Acute Eosinophilic Myocarditis and Heart Failure As the First Manifestation of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in an Asthmatic Patient: A Diagnostic Challenge.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare necrotizing vasculitis that affects multiple organ systems. Asthma is a hallmark clinical feature of the syndrome. Cardiac involvement is uncommon but constitutes one of the most severe and potentially life-threatening manifestations of the disease. We present a challenging diagnostic case of a 68-year-old woman with a history of asthma who presented with features suggestive of acute coronary syndrome and elevated cardiac troponin levels. Coronary angiography revealed only mild atheroma. The combination of a negative angiogram, marked eosinophilia, significantly elevated troponin, and cardiac dysfunction on imaging led to the diagnosis of EGPA-associated myocarditis. In this case, the disease initially manifested with cardiac symptoms, followed by subsequent renal impairment. Corticosteroid and immunosuppressive therapy effectively and rapidly controls disease activity. A multidisciplinary approach is essential in achieving optimal patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.